- Why diversity and inclusion in clinical trials are crucial?
- Understanding critical barriers to minority and underserved patient communities participation in clinical trials
- Equity and Inclusion of Rare Disease Patients – A Must on Many Levels
- What can the industry do to promote more diversity in the future?
- Latest guidelines that make healthcare more inclusive
Moderator:
Gunnar Schroefel, Senior Director Global Patient Advocacy, Daiichi Sankyo
Panelists:
Ify Osunkwo, Chief Patient Officer, Novo Nordisk Rare Disease
Naomi Litchfield, Director, Patient Advocacy, Bionical Emas
Dr Sondra Butterworth CEO & Founder, RareQoL and EDIRA
Amy Yarker, Senior Business Development Manager, NIHR Research
Nikul Bakshi, Research Involvement Lead, Parkinson’s UK